Table 2

Data for the extent and half-life of inversion calculated by deconvolution or area analysis

Control GroupClofibrate Treated Group
RatFit1/22-ainv. (min)RatFit1/22-a inv. (min)
Decon2-aAUC2-bDecon2-aAUC2-b
10.650.6914.590.910.826.0
20.790.7610.0100.780.795.0
30.670.6916.5110.810.786.0
40.750.788.0120.740.756.5
50.730.8015.0130.800.825.5
60.780.8520.0140.810.8919.0
70.730.8113.0150.670.7011.0
82-c 160.750.787.0
Mean0.730.7213.90.780.798.3
S.E.M.0.020.021.40.020.021.6
p2-d .110.078.029
  • 2-a Data obtained by the polyexponential deconvolution method.

  • 2-b Data based on AUC analysis.

  • 2-c Rat 8 was excluded because of problems during blood sampling.

  • 2-d P (unpaired, two-way, t test) for the comparison of the mean data for control with clofibrate treated animals for each parameter, respectively.